Covered CA: 2021 Marketplace Premiums Could Increase 40% Due To COVID-19

By Amy Lotven / March 24, 2020 at 3:15 PM
The costs of testing and treatment for COVID-19 could reach up to $251 billion nationwide in the first year, which could hike premiums by up to 40% in 2021, but a reinsurance mechanism that helps mitigate the unforeseen costs for the individual, employer and Medicaid managed care programs could provide needed certainty, according to analysis by Covered California Chief Actuary John Bertko. The report finds the one-year costs of diagnosing and treating COVID-19 could range from $34 billion to $251...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.